Posted by SLS on June 7, 2019, at 19:12:06
In reply to Re: SAGE-217 » beckett2, posted by Hugh on June 7, 2019, at 18:45:22
> Sage-217 is the pill version of brexanolone. The IV version of this drug, Zulresso, was approved by the FDA a few months ago. It's the first drug ever approved for postpartum depression. One of its advantages is that it starts to work within days, not weeks. There are also clinical trials underway for Sage-217 and major depressive disorder, insomnia, and bipolar depression.
Clinical trials of Sage-217 (zuranolone) for Major Depressive Disorder have been underway for awhile. The company might be looking at it for bipolar depression as well.
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.- George Bernard Shaw
poster:SLS
thread:1104754
URL: http://www.dr-bob.org/babble/20190513/msgs/1104777.html